IMR Press / JMCM / Volume 1 / Issue 1 / DOI: 10.31083/j.jmcm.2018.01.008
Open Access Research article
Re-assembled Casein Micelles for Oral Delivery of Chemotherapeutic Combinations to Overcome Multidrug Resistance in Gastric Cancer
Show Less
1 The Laboratory of Food Physical Chemistry and Biopolymeric Delivery Systems for Health, Department of Biotechnology and Food Engineering, Technion-Israel Institute of Technology, Haifa 3200000, Israel
2 Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology, Haifa 3200000, Israel
3 The Fred Wyszkowski Cancer Research Laboratory, Department of Biology, Technion-Israel Institute of Technology, Haifa 3200000, Israel
4 Current address: Department of Psychology and Brain Sciences, University of Massachusetts Amherst, MA, 01003, USA
livney@technion.ac.il (Yoav D. Livney)
J. Mol. Clin. Med. 2018, 1(1), 55–65; https://doi.org/10.31083/j.jmcm.2018.01.008
Revised: 22 November 2017 | Accepted: 3 December 2017 | Published: 20 January 2018
Abstract

Multidrug resistance (MDR) mediated by ATP-dependent efflux transporters continues to be a dominant obstacle towards curative cancer therapy. We have previously demonstrated the ability of $\beta $-casein micelles ($\beta $-CM) to orally deliver a combination of individually encapsulated hydrophobic cargo of drugs and chemosensitizers designed to overcome MDR in gastric cancer. Herein we investigated the potential of re-assembled casein micelles (rCM) to serve as a target-activated delivery platform comprising a synergistic duo of a chemotherapeutic drug (paclitaxel) and a P-glycoprotein-specific transport inhibitor (tariquidar). The high binding affinity of paclitaxel and tariquidar to rCM was demonstrated by spectrofluorometry. Furthermore, solubilization of the drugs and suppression of crystal growth was shown by light microscopy and dynamic light scattering. A remarkable antitumor activity and complete MDR reversal were demonstrated in the in vitro cytotoxicity assay against MDR human gastric carcinoma cells overexpressing P-glycoprotein. The structure and cytotoxic activity of drug-loaded rCM were completely retained after freeze-drying and reconstitution as in $\beta $-CM. Hence, our findings highlight the great potential of casein-based nanovehicles as efficient platforms for oral delivery and local target-activated release of synergistic hydrophobic drug combinations to treat gastric cancer, and overcome of cancer chemoresistance, and for the possible treatment of non-malignant gastric disorders.

Keywords
Re-assembled-casein micelles
Target-activated oral delivery
Gastric cancer
Chemotherapeutics
Paclitaxel
Multidrug resistance
Efflux pumps
Chemosensitizers
Tariquidar
Figures
Fig. 1.
Share
Back to top